spacer
home > pmps > spring 2019 > a toxic conversation
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

A Toxic Conversation

A cleanroom is one of the biggest single investments any business is likely to make. There are many great reasons why companies literally cannot afford to get it wrong, so it makes sense to ensure it is kept operational for as long as possible. The fact of the matter is that overspecifying on sterilisation could well be increasing the lifetime cost of cleanrooms through the wholly avoidable degradation of furniture and equipment.

All fixtures and fittings in cleanrooms must facilitate Good Manufacturing Practice, meaning that materials from which they are constructed need to be chemically inert. It should also be tough enough to withstand the regular sterilisation, which is why austenitic stainless steel has always been such a common feature in cleanroom design. Furniture and other equipment built from this material will maintain its structural integrity for decades, not years. However, this is only the case when it is looked after properly, which means matching it to the chosen sterilisation option and also ensuring it is not at risk from detergents and disinfectants.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Sue Springett is Commercial Manager at Teknomek, which produces hygienic furniture and equipment. Having previously held similar positions in manufacturing and service industries, she has helped Teknomek introduce a series of new products specifically for cleanroom users.
spacer
Sue Springett
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

CPI to showcase results from BioStreamline project developing novel biotherapeutics

CPI, a UK-based technology innovation centre and a founding member of the High Value Manufacturing Catapult, announced today that it will host an event in Darlington, UK on 26 June 2019 to disseminate the results of the £11.2M BioStreamline project to optimise the development of novel therapeutics. During the event, the project partners — Lonza Biologics, UCB Celltech, Sphere Fluidics, Horizon Discovery Group plc (Horizon), Alcyomics Ltd and CPI — will showcase the results and discuss the potential impact on overcoming some of the most significant shortcomings of the biologics supply chain.
More info >>

White Papers

Nasal Drug Delivery with a Focus on Chronic Rhino-Sinusitis

Aptar Pharma

Aptar Pharma have hosted a scientific roundtable on “Nasal drug delivery with a focus on chronic rhino‑sinusitis”. This international scientific forum was held in Paris, France on November 13th 2012. The roundtable was organized to explore and exchange views on the science of various forms of sinusitis and its related unmet medical needs.
More info >>

 
Industry Events

INTERPHEX 2020

15-17 July 2020, Javits Center NYC


More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement